News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
113,743 Results
Type
Article (5108)
Company Profile (18)
Press Release (108616)
Section
Business (39979)
Career Advice (137)
Deals (6894)
Drug Delivery (8)
Drug Development (14025)
Employer Resources (11)
FDA (2505)
Job Trends (3119)
News (61847)
Policy (4346)
Tag
2027 Biotech Bay Standard (1)
Academia (255)
Accelerated approval (12)
ADA (16)
Adcomms (1)
Allergies (51)
Alliances (4737)
ALS (33)
Alzheimer's disease (313)
Antibody-drug conjugate (ADC) (117)
Approvals (2753)
Artificial intelligence (83)
ASCO (100)
Autoimmune disease (57)
Automation (7)
Bankruptcy (51)
Best Places to Work (2541)
BIO (14)
Biosimilars (45)
Biotechnology (13)
Bladder cancer (65)
Brain cancer (10)
Breast cancer (197)
Cancer (1395)
Cardiovascular disease (104)
Career advice (132)
Career pathing (4)
CAR-T (62)
CDC (3)
Celiac Disease (1)
Cell therapy (174)
Cervical cancer (15)
Clinical research (13613)
Collaboration (279)
Compensation (184)
Complete response letters (4)
COVID-19 (368)
CRISPR (24)
C-suite (71)
Cystic fibrosis (25)
Data (2396)
Decentralized trials (1)
Depression (27)
Dermatology (32)
Diabetes (160)
Diagnostics (1205)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (53)
Drug pricing (16)
Drug shortages (3)
Duchenne muscular dystrophy (79)
Earnings (34345)
Editorial (3)
Employer branding (3)
Employer resources (9)
Events (18904)
Executive appointments (86)
FDA (3473)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (15)
Funding (179)
Gene editing (44)
Generative AI (4)
Gene therapy (125)
GLP-1 (207)
Government (727)
Grass and pollen (2)
Guidances (297)
Healthcare (3150)
Hematology (48)
HIV (18)
Huntington's disease (7)
IgA nephropathy (30)
Immunology and inflammation (66)
Immuno-oncology (14)
Indications (61)
Infectious disease (439)
Inflammatory bowel disease (53)
Influenza (30)
Intellectual property (31)
Interviews (23)
IPO (4486)
IRA (1)
Job creations (731)
Job search strategy (119)
JPM (8)
Kidney cancer (11)
Labor market (23)
Layoffs (120)
Leadership (1)
Legal (720)
Liver cancer (15)
Longevity (1)
Lung cancer (182)
Lymphoma (181)
Machine learning (5)
Management (2)
Manufacturing (135)
Marketing (1)
MASH (62)
Medical device (2460)
Medtech (2488)
Mergers & acquisitions (2635)
Metabolic disorders (349)
mRNA (27)
Multiple sclerosis (48)
NASH (2)
Neurodegenerative disease (81)
Neuropsychiatric disorders (12)
Neuroscience (570)
NextGen: Class of 2026 (882)
Non-profit (510)
Now hiring (6)
Obesity (130)
Opinion (17)
Ovarian cancer (58)
Pain (43)
Pancreatic cancer (43)
Parkinson's disease (64)
Partnered (3)
Patents (56)
Patient recruitment (91)
Peanut (16)
People (3868)
Pharmaceutical (1)
Pharmacy benefit managers (6)
Phase 1 (3265)
Phase 2 (5608)
Phase 3 (5848)
Pipeline (3359)
Policy (17)
Postmarket research (508)
Preclinical (1031)
Press Release (4)
Prostate cancer (91)
Psychedelics (1)
Radiopharmaceuticals (57)
Rare diseases (207)
Real estate (653)
Recruiting (4)
Regulatory (3887)
Reports (16)
Research institute (247)
Resumes & cover letters (7)
Rett syndrome (8)
RNA editing (4)
RSV (21)
Schizophrenia (34)
Series A (26)
Series B (23)
Sickle cell disease (27)
Special edition (4)
Spinal muscular atrophy (21)
Sponsored (3)
Startups (369)
Stomach cancer (2)
Supply chain (16)
Tariffs (12)
The Weekly (4)
Vaccines (232)
Venture capital (15)
Weight loss (87)
Women's health (26)
Worklife (4)
Date
Last 7 days (79)
Last 30 days (361)
Last 365 days (6859)
2026 (3508)
2025 (7153)
2024 (7527)
2023 (8131)
2022 (9522)
2021 (9448)
2020 (8667)
2019 (7256)
2018 (5723)
2017 (6376)
2016 (4714)
2015 (5680)
2014 (3712)
2013 (2534)
2012 (2984)
2011 (3149)
2010 (2924)
Location
Africa (109)
Alabama (12)
Arizona (63)
Arkansas (3)
Asia (7015)
Australia (1001)
California (3106)
Canada (800)
China (216)
Colorado (134)
Connecticut (104)
Delaware (141)
Europe (17071)
Florida (425)
Georgia (84)
Hawaii (1)
Idaho (9)
Illinois (269)
India (15)
Indiana (161)
Japan (292)
Kansas (14)
Kentucky (11)
Louisiana (19)
Maine (21)
Maryland (401)
Massachusetts (2200)
Michigan (56)
Minnesota (132)
Mississippi (1)
Missouri (34)
Montana (3)
Nevada (26)
New Hampshire (10)
New Jersey (1178)
New Mexico (3)
New York (802)
North Carolina (392)
Northern California (1643)
Ohio (86)
Oregon (1)
Pennsylvania (510)
Puerto Rico (1)
Rhode Island (3)
South America (169)
South Carolina (4)
Southern California (1213)
Tennessee (34)
Texas (345)
United States (10863)
Utah (87)
Virginia (62)
Washington D.C. (6)
Washington State (222)
West Virginia (1)
Wisconsin (39)
113,743 Results for "45".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
June 30, 2026
·
17 min read
Press Releases
ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
June 30, 2026
·
7 min read
Press Releases
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
June 11, 2026
·
7 min read
Press Releases
Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segment
June 4, 2026
·
4 min read
Press Releases
The Canadian Cancer Society welcomes Ontario’s move to lower colorectal cancer screening age to 45
May 8, 2026
·
2 min read
Mergers & acquisitions
AbbVie sinks talons into KRAS with right to buy Kestrel for up to $1.45B
AbbVie is setting up a shot to buy Kestrel Therapeutics down the line, as the biotech doses patients in a Phase 1 trial for the oral pan-KRAS inhibitor KST-6051 in solid tumors.
April 28, 2026
·
1 min read
·
Annalee Armstrong
Deals
Bayer ends multi-year M&A drought with up to $2.45B Perfuse buy
For $300 million upfront, Bayer is purchasing Perfuse Therapeutics to advance an eye implant for glaucoma and diabetic retinopathy, marking the company’s first pharma acquisition since 2021.
May 6, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
March 19, 2026
·
15 min read
Manufacturing
Lilly invests $4.5B in Indiana manufacturing, opens doors of 1st genetic medicine site
Eli Lilly’s latest manufacturing expansion will support production of obesity blockbusters and next-gen assets, while the new Lilly Lebanon Advanced Therapies site will take experimental genetic medicines from research to commercialization.
May 8, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study
June 2, 2026
·
6 min read
1 of 11,375
Next
